Found: 44
Select item for more details and to access through your institution.
Pandemic Influenza Planning: Addressing the Needs of Children.
- Published in:
- American Journal of Public Health, 2009, v. 99, n. S2, p. S255, doi. 10.2105/AJPH.2009.159970
- By:
- Publication type:
- Article
Expected Rates of Select Adverse Events After Immunization for Coronavirus Disease 2019 Vaccine Safety Monitoring.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Incorporating Research and Evaluation into Pandemic Influenza Vaccination Preparedness and Response.
- Published in:
- Emerging Infectious Diseases, 2014, v. 20, n. 4, p. 713, doi. 10.3201/eid2004.140224
- By:
- Publication type:
- Article
Medical Expenditures for Children with an Autism Spectrum Disorder in a Privately Insured Population.
- Published in:
- Journal of Autism & Developmental Disorders, 2008, v. 38, n. 3, p. 546, doi. 10.1007/s10803-007-0424-y
- By:
- Publication type:
- Article
Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 6, p. 980, doi. 10.1093/cid/civ423
- By:
- Publication type:
- Article
Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 10, p. e58, doi. 10.1093/cid/civ061
- By:
- Publication type:
- Article
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 325, n. 8, p. 780, doi. 10.1001/jama.2021.0600
- By:
- Publication type:
- Article
Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases -- United States, 2024.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 21, p. 501, doi. 10.15585/mmwr.mm7321e1
- By:
- Publication type:
- Article
Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years -- United States, July 13, 2022-March 13, 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 31, p. 850, doi. 10.15585/mmwr.mm7231a4
- By:
- Publication type:
- Article
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years -- United States, June 17, 2022-May 7, 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 23, p. 621, doi. 10.15585/mmwr.mm7223a2
- By:
- Publication type:
- Article
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5--11 Years -- United States, October 12--January 1, 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 2, p. 39, doi. 10.15585/mmwr.mm7202a5
- By:
- Publication type:
- Article
Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak -- United States, May 22-October 21, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 49, p. 1555, doi. 10.15585/mmwr.mm7149a4
- By:
- Publication type:
- Article
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 44, p. 1401, doi. 10.15585/mmwr.mm7144a3
- By:
- Publication type:
- Article
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years -- United States, June 18, 2022-August 21, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 35, p. 1115, doi. 10.15585/mmwr.mm7135a3
- By:
- Publication type:
- Article
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years -- United States, May 17-July 31, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 33, p. 1047, doi. 10.15585/mmwr.mm7133a3
- By:
- Publication type:
- Article
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 30, p. 971, doi. 10.15585/mmwr.mm7130a4
- By:
- Publication type:
- Article
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines -- United States, February 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 11, p. 416, doi. 10.15585/mmwr.mm7111a4
- By:
- Publication type:
- Article
Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Survey of State Practices During the 2004-2005 Influenza Vaccine Shortage.
- Published in:
- Public Health Reports, 2007, v. 122, n. 3, p. 311, doi. 10.1177/003335490712200304
- By:
- Publication type:
- Article
Reports of Expired Live Attenuated Influenza Vaccine Being Administered -- United States, 2007-2014.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2014, v. 63, n. 35, p. 773
- By:
- Publication type:
- Article
Notes from the Field.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2014, v. 63, n. 4, p. 81
- By:
- Publication type:
- Article
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2012-13 Influenza Season.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2012, v. 61, n. 32, p. 613
- By:
- Publication type:
- Article
Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US—Reply.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
- Published in:
- 2021
- By:
- Publication type:
- journal article
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009–2017.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 12, p. 2928, doi. 10.1111/bcp.13736
- By:
- Publication type:
- Article
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 7, p. 249, doi. 10.15585/mmwr.mm7107e1
- By:
- Publication type:
- Article
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 3, p. 90
- By:
- Publication type:
- Article
COVID-19 Vaccine Safety in Children Aged 5-11 Years -- United States, November 3-December 19, 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 51/52, p. 1755, doi. 10.15585/mmwr.mm705152a1
- By:
- Publication type:
- Article
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
First Month of COVID-19 Vaccine Safety Monitoring -- United States, December 14, 2020-January 13, 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 8, p. 283, doi. 10.15585/mmwr.mm7008e3
- By:
- Publication type:
- Article
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2020, v. 69, n. 38, p. 1355, doi. 10.15585/mmwr.mm6938e2
- By:
- Publication type:
- Article
Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Notes from the Field: Vaccine Administration Errors Involving Recombinant Zoster Vaccine - United States, 2017-2018.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2253845, doi. 10.1001/jamanetworkopen.2022.53845
- By:
- Publication type:
- Article
Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 7, p. e2222241, doi. 10.1001/jamanetworkopen.2022.22241
- By:
- Publication type:
- Article